Does TOFACITINIB Cause Increased appetite? 146 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 146 reports of Increased appetite have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
146
Reports of Increased appetite with TOFACITINIB
0.1%
of all TOFACITINIB reports
0
Deaths
14
Hospitalizations
How Dangerous Is Increased appetite From TOFACITINIB?
Of the 146 reports, 14 (9.6%) required hospitalization, and 6 (4.1%) were considered life-threatening.
Is Increased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 146 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Increased appetite?
SEMAGLUTIDE (980)
RISPERIDONE (808)
TIRZEPATIDE (640)
OLANZAPINE (556)
ARIPIPRAZOLE (465)
QUETIAPINE (389)
RUXOLITINIB (287)
PREDNISONE (265)
PREGABALIN (265)
GABAPENTIN (253)
Which TOFACITINIB Alternatives Have Lower Increased appetite Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN